| Application no. and date | 19718562.2 (espacenet) (Federated) (European Patent Register), 20190405 | | Patent/reg. no. and date | DK/EP 3773713, 20250709 | | Publication date | 20210217 | | Priority no. and date | US 201862653731 P, 20180406 | | EP pub. no. and date |
EP 3773713 20210217 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V494357DK00 | | Inventor | MURPHY, Andrew J., c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw
Mill River Road Tarrytown
New York 10591, US,
GROMADA, Jesper, c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw
Mill River Road Tarrytown
New York 10591, US,
STEVIS, Panayiotis, c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw
Mill River Road Tarrytown
New York 10591, US,
ALTAREJOS, Judith, c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw
Mill River Road Tarrytown
New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61P 3/00 (2006.01) , A61P 3/04 (2006.01) , A61P 3/14 (2006.01) , C07K 16/28 (2006.01) | | Title | Leptinreceptoragonistantistof til anvendelse i forøgelse af knoglemasse hos et individ, der lider af metabolisk dysfunktion eller hypoleptinæmI | | Int. application no. | US2019026173 | | Int. publication no. | WO2019195796 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
